SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Status unconfirmed · Phase 4

Conditions studied: HIV Infections, Lipodystrophy

In brief

SHARE: Simple HAART with Abacavir, Reyataz, and Epivir

Key facts

Study ID

NCT00426296

Run by

Clinical Alliance for Research & Education - Infectious Diseases, LLC.

Starts

2006-08-01

Last updated by the study team

2007-11-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Currently taking abacavir/lamivudine (Epzicom) in combination with atazanavir (Reyataz) boosted with ritonavir (Norvir) as first antiretroviral regimen
• Viral load <50 copies/ml

You may not qualify if…

• Viral load >50 copies/ml
• Having taken more than one antiretroviral regimen

Where it is running

• Whitman-Walker Clinic — Washington D.C., District of Columbia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.